Vadala Shawn sold $3.2M of MTD

Vadala Shawn (Chief Financial Officer) sold 2,240 shares of METTLER TOLEDO INTERNATIONAL INC/ (MTD) at $1432.00 ($3.21M total) on 2026-08-03.

Original reporting
SEC EDGAR · Vadala Shawn
Published Aug 5, 2026, 1:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 5, 2026, 1:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$MTD
Neutral
medium confidence
Mentioned
$MTD
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MTDNeutralLow
01

Why it matters

The newest fact is the disclosed open-market sale details (shares, price, total value, and post-transaction holdings). There is no accompanying corporate event or new company-specific fundamental information.

02

Market read

Traders may note insider selling as a sentiment datapoint, but the filing alone is unlikely to drive a durable repricing without additional catalysts.

03

What to watch

The article lacks context on total holdings, prior sale patterns, tax/option exercises, and whether other insiders sold around the same time.

Relevance 6/10Novelty 3/10Timing: filed Aug 5, covering sale dated Aug 3

Background

The article is an SEC Form 4 insider transaction disclosure for Mettler-Toledo International, reported by CFO Shawn Vadala.

Company-level read

Ticker impact

$MTDNeutralMedium confidence
Context

CFO Shawn Vadala sold 2,240 shares of Mettler-Toledo at $1,432/share for about $3.21M, disclosed via SEC Form 4.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven rather than fundamental.

Evidence & confidence

The filing provides transaction size, price, and post-sale holdings, but no accompanying company-specific news, guidance, or legal/regulatory catalyst.

Market effects

No clear sector read-through from a single CFO open-market sale.

None indicated.

None indicated.

Counterpoint

Insider sales can be planned for liquidity or diversification; the absence of a stated 10b5-1 plan does not automatically imply negative information.

Key entities

  • Mettler-Toledo International Inc.

    Subject of the Form 4 insider sale disclosure.

  • Shawn Vadala

    Chief Financial Officer who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MTDHighAI 8/10

Biotech funding froze. Why has this lab instrument maker climbed 25% anyway?

Mettler-Toledo's stock rose 25% despite biotech funding freeze. Management's 2026 EPS guidance of $47.70-$47.90 exceeds consensus, with 2027 guidance also above expectations. Analysts' average price target is $1,590, but some, like Jefferies, raised targets to $1,930. The company expects $900M in free cash flow, supporting an $875M share buyback. Growth drivers include pharmacopeia revisions and GLP-1 manufacturing. Investors should evaluate service revenue and hardware cycles.

$MTDMed

Biotech funding froze. Why has this lab instrument maker climbed 25% anyway? By Investing.com RSS CTA

Mettler-Toledo International (MTD) has risen 25.2% in two months, defying a biotech funding slowdown. The company, a key supplier of precision lab instruments, benefits from regulatory requirements in commercial drug production. Q3 results showed $1.09B revenue, $12.57 adjusted EPS, and strong margins. Management's 2026-2027 EPS guidance exceeds Wall Street estimates, with free cash flow supporting share buybacks.

$MTDMedAI 8/10

What Mettler-Toledo International (MTD) Said on Its Q3 Earnings Call

Mettler-Toledo (MTD) reported Q3 gross margin expansion to 59.8% and adjusted operating profit growth of 8%. The company raised its 2026 sales growth forecast to 5% and issued 2027 guidance, expecting 5% sales growth and adjusted EPS of $52.50-$53.50. Management highlighted opportunities in automation, digitalization, and U.S. onshoring, with potential upside from AI-driven instrument upgrades.

$MTDMed

Jefferies raises Mettler-Toledo stock price target on solid growth

Jefferies raised its price target for Mettler-Toledo (MTD) to $1,930, citing strong Q3 results with 6% local currency growth and improved 2026 outlook. The stock trades near its 52-week high, up 26.5% in six months. MTD reported Q3 adjusted earnings of $12.57 per share and revenue of $1.09 billion, both exceeding estimates. The company provided initial 2027 guidance with 5% growth and EPS of $52.50-$53.50, above consensus.